Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by thadeushon Apr 06, 2022 10:20pm
261 Views
Post# 34582830

This has got to be good for TLT...

This has got to be good for TLT...
Emmanuelle Gattuso remembers well the moment she was told she had breast cancer.
 
"I was like stunned. I really was," she told CTV National News.
 
Gattuso was diagnosed in 2002, the same year her mother had passed away from ovarian cancer.
 
"I was very lucky with Stage 1 and had radiation for five-and-a-half weeks," said Gattuso.
 
She was treated at the Princess Margaret Cancer Centre in Toronto, a world-renowned centre for breakthrough cancer research.
 
On Tuesday, Gattuso along with the family of her late husband -- Canadian broadcast mogul and philanthropist Allan Slaight -- announced that the charitable foundations they manage are giving $50 million to support cancer research at the facility.
 
"It's an incredible place to be treated," she said.
 
The gift to The Princess Margaret Cancer Foundation is being made in memory of Slaight. He died last year at the age of 90.
 
Fighting back tears, Gattuso said, "This is a way to really honour Allan and give a gift that will have a lasting legacy. Not only for patients here, but all over the world."
 
The money comes at a time when cancer diagnoses are expected to "significantly" rise post-pandemic.
 
"Unfortunately we lose 232 Canadians every day to cancer," said Dr. Miyo Yamashita, president and CEO of the Princess Margaret Cancer Foundation.
 
"It's the leading cause of death in this country."
 
While COVID-19 has taken a terrible toll, killing more than 37,000 people in Canada, Yamashita says an estimated 170,000 have died of cancer since the start of the pandemic.
 
The donation will be used to bring in top researchers and encourage innovative and "unconventional" research.
 
"It's going to see those early stage research projects, the research that might be considered out of the box creative," said Dr. Aaron Schimmer, the centre's director of research.
 
"Maybe even high risk research that might have a high chance of failure, but if successful moving to game changing science," he added.
 
Gattuso and her late husband have been generous donors of the hospital. They gave millions of dollars to fund a Rapid Diagnostic Unit and they made a $50 million donation back in 2013, which was at the time the largest private gift in Canada to fund cancer research.
 
"It's really important to give back," said Gattuso.

https://www.ctvnews.ca/health/coronavirus/world-renowned-toronto-cancer-hospital-receives-50-million-donation-1.5849506
<< Previous
Bullboard Posts
Next >>